Welcome to HealthyDogPetCo Blog

Sitemap xml

.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group. . Khayat-Khoei M, et al. J Neurol. 2021 Sep 4:1-14. doi: 10.1007/s00415-021-10780-7. Online ahead of print. J Neurol. 2021. PMID: 34480607 .
.
Characterizing DNA preservation in degraded specimens of Amara alpina (Carabidae: Coleoptera).
Heintzman PD, Elias SA, Moore K, Paszkiewicz K, Barnes I. Heintzman PD, et al. . Lehnertz B, et al. Blood. 2021 Sep 9:blood.2021010745. doi: 10.1182/blood.2021010745. Online ahead of print. Blood. 2021. PMID: 34499717

top
top
Page
Menu
News
Home Print viewSitemap